Scientists are collaborating to develop and evaluate new approaches to vaccines

Researchers around the world are pursuing many avenues to improve treatment and prevention approaches to controlling pneumococcal disease. The pneumococcal vaccine program at PATH is reaching out to partner with scientists and manufacturers to advance their research toward preventing pneumonia and other illnesses caused by pneumococcus. We are working from initial discovery through clinical trials to shorten the timeline for developing vaccines to serve the countries in greatest need.

In addition to supporting the development of innovative vaccine candidates, we also conduct and support research to meet general needs within the field of pneumococcal vaccine research. Research needs across the field include cataloging pneumococcal strain collections, identifying models or assays for use in preclinical testing of potential vaccines, defining burden of illness of pneumococcal disease in various geographic locations, improving diagnostic tools, and identifying production processes so that vaccines are affordable for distribution by public health systems in low-income countries.

Articles from the scientific literature on pneumococcus are available through PATH's Vaccine Resource Library.